KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Assets: 2009-2024

Historic Assets for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $986.3 million.

  • Dynavax Technologies' Assets fell 10.87% to $946.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $946.5 million, marking a year-over-year decrease of 10.87%. This contributed to the annual value of $986.3 million for FY2024, which is 1.09% down from last year.
  • According to the latest figures from FY2024, Dynavax Technologies' Assets is $986.3 million, which was down 1.09% from $997.1 million recorded in FY2023.
  • Dynavax Technologies' Assets' 5-year high stood at $1.0 billion during FY2021, with a 5-year trough of $353.3 million in FY2020.
  • Moreover, its 3-year median value for Assets was $986.3 million (2024), whereas its average is $989.7 million.
  • As far as peak fluctuations go, Dynavax Technologies' Assets surged by 194.18% in 2021, and later decreased by 5.14% in 2022.
  • Dynavax Technologies' Assets (Yearly) stood at $353.3 million in 2020, then skyrocketed by 194.18% to $1.0 billion in 2021, then declined by 5.14% to $985.9 million in 2022, then increased by 1.14% to $997.1 million in 2023, then decreased by 1.09% to $986.3 million in 2024.